BUSINESS● LOW2h ago · Sep 17, 2026, 11:28 AM
Novo and Orbis ink drug discovery deal worth up to $1.4B
Seeking Alpha Tech · global
Novo and Orbis have entered into a drug discovery deal potentially valued at up to $1.4 billion. This agreement signifies a major collaboration in the pharmaceutical research sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowGabon: understanding Libreville's sleight of hand to get out of debtJeune AfriqueBUSINESS14m agoPicton Mahoney Fortified Core Bond Fund declares CAD 0.032 dividendSeeking Alpha Tech